Publications

Sonneveld N, Jackson J, Dey A, Lambert SB, Clark KK, Cowie BC, Macartney K, Beard F. Australian vaccine preventable disease epidemiological review series: Hepatitis B, 2000-2019. Communicable Diseases Intelligence (2018) 2024;48. doi: 10.33321/cdi.2024.48.44. [Full text]

van der Kooi S, Beard F, Dey A, McIntyre P, Imai C, Amin J. Pertussis notifications decline in Australia during COVID-19 non-pharmaceutical interventions, 2020-2021. Communicable Diseases Intelligence (2018) 2024;48. doi: 10.33321/cdi.2024.48.24. [Abstract]

Glover C, Deng L, Larter C, Brogan C, Richardson O, Huang YA, Kay E, Macartney K, Wood N. Surveillance of adverse events following immunisation in Australia, COVID-19 vaccines, 2021. Communicable Diseases Intelligence (2018) 2024;48. doi: 10.33321/cdi.2024.48.2. [Full text]

Glover C, Deng L, Larter C, Brogan C, Richardson O, Huang YA, Kay E, Macartney K, Wood N. Surveillance of adverse events following immunisation in Australia annual report, 2021. Communicable Diseases Intelligence (2018) 2024;48. doi: 10.33321/cdi.2024.48.1. [Full text]

Imai C, Jayasinghe S, McRae J, Li-Kim-Moy J, Chiu C, Macartney K, Burns P, Cooper K, Cheng AC, Gibney K, Giles M, Jones C, Korman T, Liu B, Crawford NW; Australian Technical Advisory Group on Immunisation (ATAGI). Surveillance of adverse events following immunisation in Australia annual report, 2021.. Communicable Diseases Intelligence (2018) 2024;48. doi: 10.33321/cdi.2024.48.25. [Full text]

Kandasamy R, Gurung M, Shrestha S, Gautam MC, Kelly S, Thorson S, Ansari I, Gould K, Hinds J, Kelly DF, Murdoch DR, Pollard AJ, Shrestha S. Decline in pneumococcal vaccine serotype carriage, multiple-serotype carriage, and carriage density in Nepalese children after PCV10 introduction: a pre-post comparison study. Vaccine 2024:S0264-410X(24)00564-4. doi: 10.1016/j.vaccine.2024.05.018 . [Full text]

Marsland MJ, Thomson TN, O'Brien HM, Peach E, Bellette J, Humphreys N, McKeon CA, Cross W, Moso MA, Batty M, Nicholson S, Karapanagiotidis T, Lim CK, Williamson DA, Winkler N, Koirala A, Macartney K, Glynn-Robinson A, Stewart T, Minko C, Snow KJ, Black J, Friedman ND. Serosurvey for Japanese encephalitis virus antibodies following an outbreak in an immunologically naïve population, Victoria, 2022: a cross-sectional study. Medical Journal of Australia 2024. doi: 10.5694/mja2.52344 . [Full text]

Baldwin Z, Hueston L, Roberts-Witteveen A, Stanley P, Sheel M, Winkler N, Koirala A, Macartney K, Case J, Hope K, Glasgow KM. The seroprevalence of antibodies to Japanese encephalitis virus in five New South Wales towns at high risk of infection, 2022: a cross-sectional serosurvey. Medical Journal of Australia 2024. doi: 10.5694/mja2.52320 . [Full text]

Muttucumaru R, Lau CL, Leeb A, Mills DJ, Wood N, Furuya-Kanamori L. Post-marketing surveillance of 10,392 herpes zoster vaccines doses in Australia. Vaccine 2024;42:3166-3171. doi: 10.1016/j.vaccine.2024.03.066 . [Full text]

Townley B, Akin D, Dimaguila GL, Sawires R, Sepulveda Kattan G, King S, Bines J, Wood N, Lambert S, Buttery J. Exploring the infectious contribution to intussusception causality using the effects of COVID-19 lockdowns in Australia: an ecological study. Clinical Infectious Diseases 2024;79:255-262. doi: 10.1093/cid/ciae084. [Abstract]